Those to benefit from Argus II are people with retinitis pigmentosa, a rare genetic disease, affecting about 100,000 people in the U.S., that results in the degeneration of the retinal photoreceptors.

Read more at
http://www.accessibilitynewsinternational.com/bionic-eye-gives-hope-to-the-blind/